-
Influenza Vaccines Market Global Forecast and Company Analysis 2025-2032, with GlaxoSmithKline, Sanofi, CSL Seqirus, AstraZeneca, Gamma Vaccines, Hualan Bioengineering, Viatris and BioDiem - ResearchAndMarkets.com
29 Jan 2025 13:32 GMT
… Market - Key Company Analysis
GlaxoSmithKline
Sanofi
CSL Seqirus
AstraZeneca
Gamma … Key Company Analysis
11.1 GlaxoSmithKline (GSK)
11.2 Sanofi
11 …
-
Postherpetic Neuralgia Market Future Trend and Analysis and Forecast 2025 to 2032 | Pfizer GlaxoSmithKline plc
27 Jan 2025 10:38 GMT
… -depth profiling -
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Teikoku Pharma …
-
Drug Discovery Market Generated Opportunities, Future Scope by 2031 | Pfizer Inc., GlaxoSmithKline LLC, Merck & Co. Inc.
17 Jan 2025 13:44 GMT
… in This Report:
• Pfizer Inc.
• GlaxoSmithKline LLC
• Merck & Co. Inc …
-
Influenza Vaccines Market In-depth Insights forecast by 2024 To 2031 | CSL Seqirus, GlaxoSmithKline plc, Sanofi
17 Jan 2025 13:44 GMT
… in This Report:
• CSL Seqirus
• GlaxoSmithKline plc
• Sanofi
• AstraZeneca
• FluGen Inc …
-
Herpes Simplex Virus (HSV) Vaccines Market Set to Witness Significant Growth by 2025-2032:Sanofi S.A,GlaxoSmithKline Plc
16 Jan 2025 07:01 GMT
… This Report:
◘ Sanofi S.A.
◘ GlaxoSmithKline Plc.
◘ Genocea Biosciences Inc.
◘ Vical …
-
Leprosy Treatment Market Set to Witness Significant Growth by 2024-2031 | Glaxo Smithcline Pharmaceuticals Ltd.
14 Jan 2025 07:48 GMT
… players Highlighted in This Report:
• Glaxo Smithcline Pharmaceuticals Ltd.
• Systopic Laboratories …
-
Pharma stocks: Biocon up 3.84% on US FDA nod for Malaysia unit; Divi’s Lab gains 0.61%, Mankind Pharma slips 3.75%, GlaxoSmithKline drops 2.42%
13 Jan 2025 06:03 GMT
… ₹2,637.10, followed by GlaxoSmithKline Pharmaceuticals and Aurobindo Pharma, which … : ₹2,637.10 (-3.75%)
GlaxoSmithKline Pharmaceuticals: ₹2,137.50 (-2 …
-
Diabetic Neuropathy Market Generated Opportunities, Future Scope 2024-2031 | Eli Lilly and Company, GlaxoSmithKline
10 Jan 2025 07:42 GMT
… Report:
• Eli Lilly and Company
• GlaxoSmithKline
• Pfizer
• Johnson & Johnson and …
-
Unlocking Extensive Growth Opportunities of Vasculitis Treatment Market by 2031 | RNL BIO Co., Ltd., GlaxoSmithKline plc
09 Jan 2025 09:28 GMT
… Report:
• RNL BIO Co., Ltd.,
• GlaxoSmithKline plc
• Novartis AG
• Troikaa Pharmaceuticals …
-
Influenza Vaccine Market Detailed in New Research Report By 2031 | GlaxoSmithKline plc (U.K.), Sanofi (France)
30 Dec 2024 14:20 GMT
… in the industry report include:
• GlaxoSmithKline plc (U.K.)
• Sanofi (France …